Advanced search×

ABCB1/MDR1 gene polymorphisms as a prognostic factor in colorectal cancer.

Int J Colorectal Dis 25(10):1167-76 (2010) PMID 20533057

To analyse the single-nucleotide polymorphisms (SNPs): ABCB1(1236C>T), ABCB1(2677G>T/A), ABCB1(3435C>T) and haplotypes in the ABCB1/MDR1 gene, which could contribute to genetic risk of colorectal cancer (CRC). Disease association between the ABCB1/MDR1 genotype, allele, haplotype frequencies and histological features, such as TNM classification, localization of primary carcinoma, grade of malignancy, histological type of tumour, lymphoid infiltration and vessel invasion were estimated. In this study, the potential role of SNPs of the ABCB1/MDR1 gene as a prognostic marker for CRC was analysed.

DOI: 10.1007/s00384-010-0961-2
Version: za2963e q8za3 q8zbd q8zc4 q8zd2 q8ze1 q8zff q8zgf

Similar articles you may find interesting…

  1. Relevance of multidrug resistance in the age of targeted therapy.

    Audio, Transactions of the IRE Profession... 12(2):246-52 (2009) PMID 19333870

    Targeted drugs inhibit specific pathways that contribute to the malignant phenotype of cancer cells. The initial success of molecularly targeted therapies raised hope that newly developed agents would evade the general mechanisms of resistance that have reduced the efficacy of traditional anticancer...
  2. Hydrogen exchange mass spectrometry: what is it and what can it tell us?

    Audio, Transactions of the IRE Professio... 397(3):967-72 (2010) PMID 20195578

    We discuss hydrogen exchange mass spectrometry and how this method can be used to learn about protein conformation and dynamics. The basic concepts of the method are described, the workflow illustrated, and a few examples of its application are provided....
  3. Genetic Polymorphisms and Individualized Tacrolimus Dosing

    Transplant Proc 42(8):3 (2010) PMID 20970601

    Of the patients, 62.8% (n = 22) were men and the overall mean age was 55 years (95% confidence interval, 48.7-62.7). The SNP distribution was: CYP3A5*3: G/G = 82.9%, A/G = 17.1%; CYP3A5*6: G/G = 88.6%, G/A = 11.4%; MDR1 C3435T: C/C = 25.7%, C/T = 62.9%, T/T = 11.4%; for MDR1 G2677T/A: G/G = 22.9%, G...